First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor episode artwork

EPISODE · Apr 10, 2025 · 57 MIN

First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor

from Lung Cancer Update

Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer. CME information and select publications here.

Episode metadata supplied by the publisher feed · Published Apr 10, 2025

Embed this episode

Ready to play

First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor

0:00 57:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Lung Cancer Update?

This episode is 57 minutes long.

When was this Lung Cancer Update episode published?

This episode was published on April 10, 2025.

Can I download this Lung Cancer Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!